Rituximab in relapsed or refractory hairy cell leukemia.

@article{Thomas2003RituximabIR,
  title={Rituximab in relapsed or refractory hairy cell leukemia.},
  author={Deborah A. Thomas and Susan M O'Brien and Carlos E Bueso-Ramos and Stefan H Faderl and Michael J Keating and Francis J Giles and Jorge E. Cortes and Hagop M Kantarjian},
  journal={Blood},
  year={2003},
  volume={102 12},
  pages={3906-11}
}
The purpose of this study was to investigate the efficacy and safety of the monoclonal antibody, rituximab, in relapsed or refractory hairy cell leukemia (HCL). Fifteen patients with relapsed or primary refractory HCL after nucleoside analogs received rituximab 375 mg/m2 weekly for a total of 8 planned doses. An additional 4 doses could be administered to responders who had not achieved complete response (CR). The overall response rate was 80%. Eight patients (53%) achieved CR, 2 (13%) attained… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 46 extracted citations

Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN • 2017

How I manage patients with hairy cell leukaemia.

British journal of haematology • 2017
View 1 Excerpt

A case of hairy cell leukemia variant.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie • 2015

Historical overview of hairy cell leukemia.

Best practice & research. Clinical haematology • 2015
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 61 references

Hairy cell leukemia: a clinical review based on 71 cases.

Annals of internal medicine • 1978
View 5 Excerpts
Highly Influenced

Leukemic reticuloendotheliosis.

View 5 Excerpts
Highly Influenced

Long-term follow-up of patients with hairy cell leukemia after cladribine treatment

A Saven, C Binian, JA Koziol
THOMAS et al BLOOD, • 2003

Effi - cacy of the anti - CD 22 recombinant immunotoxin BL 22 in chemotherapy - resistant hairy - cell leuke

RJ Kreitman, WH Wilson, K Bergeron
N Engl J Med • 2001

Rituximab dose-escalation trial in chronic lymphocytic leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2001

Similar Papers

Loading similar papers…